Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) Director Francis Hondal purchased 3,343 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The stock was bought at an average cost of $14.99 per share, with a total value of $50,111.57. Following the acquisition, the director owned 21,554 shares of the company’s stock, valued at approximately $323,094.46. The trade was a 18.36% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Bath & Body Works Trading Up 4.9%
NYSE BBWI traded up $0.73 on Monday, reaching $15.58. 18,349,612 shares of the company were exchanged, compared to its average volume of 5,908,003. The business’s fifty day moving average price is $24.58 and its 200 day moving average price is $28.11. The stock has a market capitalization of $3.21 billion, a P/E ratio of 4.62, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $41.87.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings results on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.05). The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm’s revenue was down 1.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.49 EPS. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. Equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works Dividend Announcement
Analysts Set New Price Targets
Several research firms have recently weighed in on BBWI. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, October 8th. Barclays decreased their price objective on Bath & Body Works from $28.00 to $18.00 and set an “equal weight” rating on the stock in a report on Friday. Wells Fargo & Company lowered their price objective on Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday. New Street Research set a $26.00 target price on Bath & Body Works in a research note on Monday. Finally, Jefferies Financial Group decreased their price target on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a research note on Monday, October 13th. Seven research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to MarketBeat, Bath & Body Works presently has an average rating of “Hold” and an average target price of $26.84.
Get Our Latest Research Report on BBWI
Institutional Investors Weigh In On Bath & Body Works
Institutional investors have recently modified their holdings of the company. American Century Companies Inc. raised its holdings in shares of Bath & Body Works by 2,204.1% in the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after buying an additional 4,949,796 shares during the period. Jupiter Asset Management Ltd. grew its position in Bath & Body Works by 553.2% in the 3rd quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock valued at $95,685,000 after acquiring an additional 3,145,797 shares in the last quarter. AQR Capital Management LLC increased its stake in Bath & Body Works by 267.8% during the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock worth $121,073,000 after purchasing an additional 2,907,506 shares during the period. Fuller & Thaler Asset Management Inc. increased its stake in Bath & Body Works by 115.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock worth $111,581,000 after purchasing an additional 1,973,679 shares during the period. Finally, Norges Bank acquired a new stake in shares of Bath & Body Works during the second quarter worth about $57,746,000. 95.14% of the stock is owned by institutional investors and hedge funds.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories
- Five stocks we like better than Bath & Body Works
- 5 discounted opportunities for dividend growth investors
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- Roth IRA Calculator: Calculate Your Potential Returns
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- JPMorgan and Goldman Upgrade MP Materials Amid Defense-Driven Demand Outlook
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
